The search for an effective COVID-19 treatment is gaining momentum, with public and private entities partnering to speed the process. In this fourth installment on the scientific and investment implications of COVID-19, Portfolio Manager and Research Analyst Dan Lyons explains the latest drug developments, as well as whether the U.S. can meet aggressive testing goals to reopen the economy.

Tune in to our Professional Development Series: Coaching Calls for conversations that motivate, inspire and improve your everyday.

Janus Henderson Radio

Explore our podcasts featuring professional development coaching, retirement perspectives and market insights. Subscribe on Apple Podcasts Listen on Spotify